Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury

S P Jones1, S D Trocha, M B Strange

  • 1Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.

Insights

Inflammation involves cell adhesion molecules like P-selectin, E-selectin, ICAM-1, and CD18. Genetic deficiency of these molecules significantly reduces neutrophil infiltration and heart tissue damage following myocardial infarction and reperfusion injury in mice.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Inflammation Research

Background:

  • Cell adhesion molecules (CAMs) mediate polymorphonuclear neutrophil (PMN) recruitment during inflammation.
  • Inhibiting CAMs can reduce PMN influx and tissue injury.

Purpose of the Study:

  • To investigate the temporal expression of P-selectin, E-selectin, and ICAM-1 after myocardial infarction and reperfusion (MI/R).
  • To determine the role of P-selectin, E-selectin, ICAM-1, and CD18 in PMN infiltration and myocardial injury during MI/R.

Main Methods:

  • Mice underwent 30 minutes of LAD coronary artery ischemia followed by 24 hours of reperfusion.
  • Temporal expression of P-selectin, E-selectin, and ICAM-1 was analyzed.
  • PMN infiltration and necrosis were assessed in wild-type and gene-deficient mice (P-selectin, E-selectin, ICAM-1, CD18 knockout).

Main Results:

  • Expression of P-selectin, E-selectin, and ICAM-1 peaked around 24 hours post-reperfusion.
  • Genetic deficiency in P-selectin, E-selectin, ICAM-1, or CD18 significantly attenuated PMN infiltration into the myocardium.
  • Gene-deficient mice showed significantly smaller areas of necrosis compared to wild-type controls.

Conclusions:

  • MI/R induces coronary vascular expression of P-selectin, E-selectin, and ICAM-1 in mice.
  • P-selectin, E-selectin, ICAM-1, and CD18 play critical roles in PMN sequestration and myocardial injury following MI/R.
  • Targeting these CAMs may offer therapeutic potential for reducing MI/R injury.